Company record
J&J INNOVATIVE MEDICINE
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about J&J INNOVATIVE MEDICINE.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 14 | Class II | J&J INNOVATIVE MEDICINE Drug |
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01 Presence of particulate matter. |